Navigation Links
The Bio-probe –“ Boon to women ?

With the new device called the Bio probe being developed, screening women for cervical cancer could be made lot easier.” // The Bio-probe has to be inserted into the vagina, and the woman herself can do it. The probe remains inserted for 10 seconds while it measures electrical resistance.

It is so small that women would feel more comfortable using the device than with than taking up the routine Pap smear that is being done. The Pap procedure is currently the best way to prevent cervical cancer, yet many women continue to put it off because of the complex instrumentation involved with it. Infact of women being diagnosed as having cervical cancer, almost half of them have never had a Pap smear.

Pap tests can detect abnormal cells that lead to cervical cancer but the Bio – probe works on a different principle.” It’s believed that as the normal tissues progress from normal to cancer, the amount of blood and fluid in the tissues increases, and that causes a decrease in electrical resistance," The Bio-probe measures this difference in the electrical resistance.

What is even more promising is that one need not run to a doctor to get the test done. It can be done by the patient at home conveniently. Over the next six months to 12 months, researchers will gather data to figure out whether the probe is as effective as a Pap test. If it is, this small device could make a big difference.

The bio-probe was originally created to measure changes in the menstrual cycle and has been used to help couples with infertility. Temple University will also look at using this technology to help prevent premature births by measuring cervical abnormalities.

Page: 1

Related medicine news :

1. Transdermal HRT not cardioprotective in postmenopausal women with CAD
2. Transdermal HRT not cardioprotective in postmenopausal women with Coronary Artery Disease
3. Starvation in pregnant women can cause heart disease to their children
4. Brisk Walking lowers memory loss in women
5. Young womens woes
6. Young womens woes
7. FDA approves new device to treat womens bleeding disorder
8. Hormone replacement therapy helps women
9. Breast screening among diabetic women
10. Relief to pregnant women using fertility drugs
11. Pregnant women more prone to depression
Post Your Comments:

(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, the ... affiliation with Tennessee Counseling Association. This new relationship allows TherapySites to ... Counseling Association, adding exclusive benefits and promotional offers. , "TCA is extremely excited ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... On June ... sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, ... of the city’s history as home to some of the world’s leading providers of ...
(Date:6/25/2016)... D.C. (PRWEB) , ... June 25, 2016 , ... ... discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, ... their work on several important health care topics including advance care planning, healthcare ...
(Date:6/25/2016)... ... , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors ... Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green ... hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train ...
(Date:6/24/2016)... ... 24, 2016 , ... Those who have experienced traumatic events may suffer from ... avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid this ... coping following a traumatic event. , Trauma sufferers tend to feel a range of ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) ... Improvements Act of 1976, as amended ("HSR"), with respect ... Nasdaq: CPXX ) expired effective June 24, ... As previously announced on May 31, 2016, Jazz Pharmaceuticals ... which Jazz Pharmaceuticals has commenced a tender offer for ...
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... BEIJING , June 24, 2016 Dehaier ... or the "Company"), which develops, markets and sells medical ... China , signed a strategic cooperation agreement with ... as "Hongyuan Supply Chain") on June 20, 2016, to ... Under the strategic cooperation agreement, Dehaier will leverage Hongyuan ...
Breaking Medicine Technology: